## Core Concept
Type Ia glycogen storage disease, also known as von Gierke's disease, is a genetic disorder caused by a deficiency of the enzyme glucose-6-phosphatase. This enzyme plays a crucial role in glucose metabolism, particularly in the liver, kidneys, and intestines, by catalyzing the final steps in gluconeogenesis and glycogenolysis. The deficiency leads to an inability to convert glucose-6-phosphate into glucose for release into the bloodstream.

## Why the Correct Answer is Right
The hallmarks of type Ia glycogen storage disease include:
- **Hypoglycemia**: Due to the inability to convert glucose-6-phosphate to glucose for release into the bloodstream.
- **Lactic acidosis**: Accumulation of glucose-6-phosphate leads to increased flux through the pentose phosphate pathway and increased production of lactate.
- **Hepatomegaly**: Accumulation of glycogen in the liver leads to its enlargement.
- **Hyperlipidemia**: Increased lipolysis and decreased lipoprotein lipase activity contribute to elevated lipid levels.

## Why Each Wrong Option is Incorrect
- **Option A:** Hypoglycemia is a hallmark, not an exception.
- **Option B:** Lactic acidosis is a characteristic feature, not an exception.
- **Option C:** Hepatomegaly due to glycogen accumulation is typical, not an exception.

## Why D is Correct as the Exception
- **Option D:** Muscle weakness or myopathy is not a primary feature of type Ia glycogen storage disease. Type V (McArdle's disease) and type VII (Tarui's disease) glycogen storage diseases are more commonly associated with muscle symptoms. Type Ia primarily affects the liver, kidneys, and intestines.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients with type Ia glycogen storage disease often present with **hypoglycemic episodes**, **severe lactic acidosis**, and **marked hepatomegaly**. They are also at risk for **liver adenomas** and **hepatocellular carcinoma**. Early diagnosis and management are critical.

## Correct Answer: D. Muscle weakness